By Pete Uselman
A pharmacy payment program can process transactions every day without actually working as well as it should, and that’s part of what makes payment problems difficult to spot.
A broken terminal gets attention immediately. But slower problems are easier to miss. A gradual rise in health savings card declines, an outdated billing workflow, an expanding payment card industry (PCI) scope, or steadily rising processing costs can persist much longer before someone asks whether the underlying payment program still fits the pharmacy.
Pharmacies also operate in an unusually layered payment environment. Prescription and retail transactions may run through the same point-of-sale system. FSA, HSA, and HRA cards introduce separate eligibility and certification requirements. Some pharmacies collect payments remotely or online. Long-term care pharmacies may need statement and recurring billing capabilities alongside traditional point-of-sale transactions. And to add even more complexity, those requirements change as the business evolves.
For pharmacies and the software providers that serve them, a payment health check is an opportunity to identify issues before they become larger operational, compliance, or cost problems.
Whether you’re evaluating payments for your own pharmacy or the payment experience you provide pharmacy customers, these five questions can help determine whether the program is still doing what it should.
1. Does the payment technology still fit the way the pharmacy operates?
A payment platform selected several years ago may have been a good fit for the pharmacy at the time. Since then, the business may have added new payment channels, expanded its services, or changed how it collects funds from patients. The technology needs to keep pace with those changes.
Each change creates a basic question. Can the current payment technology support that workflow cleanly?
Workarounds are often an early indicator that the answer is no. Staff may have to move between systems, enter information manually, send customers through an inconvenient payment process, or rely on payment channels that were never designed around the pharmacy’s current needs.
Device performance also belongs in this review. Frequent terminal or connectivity issues may seem like isolated support problems, but repeated disruption at the counter is ultimately a payment-program problem.
A healthy payment program accommodates the pharmacy’s current payment channels without making routine collection harder for staff or patients.
2. Are FSA, HSA, and HRA card declines increasing?
An increase in FSA, HSA or HRA card declines warrants closer review; not every decline indicates an ineligible purchase or an issue with the customer’s account.
Some declines are legitimate because the card or purchase isn’t eligible. Others can result from issues with the pharmacy’s registration, payment setup, or health savings account acceptance.
For pharmacies accepting these cards, Special Interest Group for IIAS Standards (SIGIS) registration and inventory information approval system (IIAS) capabilities can directly affect whether a transaction is approved. SIGIS notes that membership termination results in removal from the applicable IIAS or 90% Rule merchant list. Card issuers are then notified, and FSA/HRA card transactions may be declined because the merchant no longer satisfies the applicable acceptance requirements.
Even small registration problems can matter. SIGIS specifically advises pharmacies participating in its 90% Rule program to carefully verify merchant and acquirer information, as errors can result in declines.
That makes decline trends a useful diagnostic signal.
If a pharmacy begins seeing more FSA/HSA/HRA failures than expected, the first assumption should not always be that customers are presenting ineligible cards or products. The independent software vendor (ISV) and payment partner should also confirm that the pharmacy’s SIGIS status, merchant information, and underlying POS capabilities remain in order.
This is one area where proactive guidance has an outsized effect. A pharmacy should know who is responsible for monitoring its acceptance setup and who to contact when decline behavior changes.
3. Is your pharmacy PCI compliance strategy working?
A good payment security review looks beyond whether the pharmacy completes its PCI validation. The more useful question is how much cardholder data the pharmacy’s systems can access and whether the current payment architecture keeps that exposure as limited as possible.
PCI-listed point-to-point encryption, or P2PE, can help by protecting account data from the payment device to a secure decryption environment. The PCI Security Standards Council notes that a listed P2PE solution can significantly reduce applicable PCI DSS requirements, although it does not eliminate PCI obligations entirely.
For pharmacy merchants, the practical question is whether there is a deliberate strategy to keep primary account numbers out of systems that do not need them. That strategy also needs to account for current PCI requirements, including PCI DSS v4.0.1, which became effective on March 31, 2025. If the answer is unclear, the payment environment deserves another look.
4. Do you have the support you need to manage evolving payment security, risk, and network requirements?
A healthy payment program also depends on the support available when something goes wrong or industry requirements change. Pharmacies need a reliable contact for suspicious activity, chargebacks, terminal issues, and unusual decline patterns, as well as guidance on card-network requirements that may affect their business.
Visa’s Integrity Risk Program, or VIRP, is a timely example. The program introduces additional oversight for certain higher-risk payment activity, including card-not-present pharmacy transactions. For pharmacies expanding e-commerce, refill payments, or other remote payment channels, it is important to understand which requirements apply and whether any additional registration or accreditation steps are needed. Visa’s current rules outline these requirements, while NABP’s accreditation programs provide relevant options for qualifying pharmacies.
A pharmacy should not have to navigate those changes alone or discover a requirement only after transactions are affected. Part of a healthy payment program is having a partner that can explain what changed, determine how it applies, and help the merchant take the necessary steps.
5. Are your pharmacy payment processing costs still competitive?
A payment program can remain technically sound while becoming financially inefficient. Transaction volumes, payment channels, and processing costs change over time, which means pricing that was competitive at implementation may no longer be the best fit for the pharmacy’s current business.
A regular review gives merchants a clearer picture of what they are paying, why those costs have changed, and whether their rates remain competitive:
- What is the business actually paying to accept payments?
- Which parts of that cost come from interchange, network fees, processing fees, or other charges?
- Have effective rates changed over time?
- Does the pricing still make sense for the pharmacy’s current volume and mix of transactions?
A regular review helps the pharmacy understand what it pays to accept payments and spot cost increases that need an explanation. A low headline rate means little if the pharmacy can’t see the full picture.
A pharmacy that cannot tell whether its payment costs have changed has no way to know whether the program remains competitive.
Make payment health an ongoing priority
Payment health checks shouldn’t be a one-time exercise. Pharmacies change, payment technology changes, and the requirements surrounding payments change with them. An unexpected increase in FSA declines, recurring device problems, unusual fraud or chargeback activity, a significant pricing change, a new card-not-present workflow, or a relevant network-rule change should all prompt another look.
But a pharmacy shouldn’t have to wait for a problem to arise. Software providers and their payment partners can play an important role by making these conversations part of the ongoing merchant relationship.
A healthy payment program isn’t simply one that processes transactions. It’s one that continues to fit the pharmacy as its business evolves.
References
Buan, D. (n.d.). How PCI compliance impacts pharmacies (and how your software can help!). Wind River Payments.
Malone, A. (2024). Just published: PCI DSS v4.0.1. PCI Security Standards Council.
National Association of Boards of Pharmacy. (n.d.). Accreditations.
PCI Security Standards Council. (2024). What effect does the use of a PCI-listed P2PE solution have on a merchant’s PCI DSS validation?
Special Interest Group for IIAS Standards. (n.d.). 90% registration.
Special Interest Group for IIAS Standards. (n.d.). Renew membership.
Visa. (2026). Visa core rules and Visa product and service rules.


